Dr. Tadepalli Haripriya Sameeksha

Designation: Consultant
Specialization: Oculoplasty and Ocular oncology
Work Experience: 10 Years
Practice location: NN2
Days & timing of availability for each centre: 9:00 AM to 5:30 PM (Monday to Saturday)

Dr. Sameeksha has completed her MS Ophthalmology at the prestigious Post graduate institute of medical education and research, Chandigarh. She has undergone her fellowship training in oculoplasty and ocular oncology with Dr. Santosh Honavar in Hyderabad. She also did her fellowship in ocular oncology with Dr. Carol Shields and Dr. Jerry Shields at Wills eye hospital, Philadelphia. She has a special interest in treatment of Intraocular, periocular and orbital tumors, eyelid malposition abnormalities, orbital and eyelid trauma, thyroid eye disease and lacrimal disorders. She has presented several papers at national and international conferences and won awards. She is actively involved in research and has several publications to her name

Education & Training

MBBS- Seth G.S. Medical College Mumbai
MS Ophthalmology – Post Graduate institute of Medical Education and Research, Chandigarh
Fellowship in Ocular oncology and Oculoplasty with Dr. Santosh Honavar at Hyderabad and Dr. Carol Shields at Philadelphia (USA)
FRCS part 1
FICO (Clinical FICO with Merit)
FAICO (Oculoplasty)

Work Experience
10 years. Extensive training in Oculoplasty and ocular oncology as a fellow with Dr. Santosh Honavar , Dr. Carol shields and at PGIMER, Chandigarh. Areas of expertise- Intraocular, periocular and orbital tumors, eyelid malposition abnormalities, Orbital and eyelid trauma, Thyroid eye disease, Lacrimal disorders

Achievements & Awards

2017 Dr. Gangadhar Sundar award for Best Free Paper at Oculoplasty association of India (OPAI) conference 2017, Madurai 2018 Best Video award (second place) for video on management of Myasthenia gravis and CPEO at OPAI Annual meeting 2018, Jaipur 2021 Received Fellow of International council of ophthalmology (FICO) degree and passed- Part II (Clinical sciences) with Merit in October 2020. 2021 Best Challenging case presentation (first runner up) at OPAI Conference 2021 Best Oculoplasty Video (second runner up) OPAIC 2021 2022 Won first place in Oculoplasty association of India annual conference Quiz 2022 2023 Received Fellow of All India collegium of ophthalmology (FAICO) Oculoplasty degree from AIOS

Research & Publications (Number Of Indexed Papers)

1. Tadepalli SH, Shields CL, Shields JA, Honavar SG. Intraocular medulloepithelioma – A review of clinical features, DICER 1 mutation, and management. Indian J Ophthalmol 2019;67:755-62
2. Tadepalli S, Bajgai P, Dogra M, Singh SR, Sharma A et al. Ultra-Widefield Fundus Autofluorescence in Cytomegalovirus Retinitis. Ocul Immunol Inflamm. 2019 May 28:1-7
3. Shields CL, Bas Z, Tadepalli S, et al Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre British Journal of Ophthalmology Published Online First: 12 February 2020
4. Sen, Mrittika; Honavar, Santosh G; Bansal, Rolika; Sengupta, Sabyasachi1; Rao, Raksha2; Kim, Usha3; Sharma, Mukesh4; Sachdev, Mahipal5; Grover, Ashok K6; Tadepalli, Sameeksha72; and the members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) Study Group Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1, Indian Journal of Ophthalmology: July 2021 – Volume 69 – Issue 7 – p 1670-1692
5. Bas, Zeynep MD∗; Dalvin, Lauren A. MD∗,†; Tadepalli, Sameeksha MD∗; Rao, Raksha MD∗; Shah, Amish MD, PhD‡; Leahey, Ann M. MD‡; Shields, Carol L. MD∗ Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients, Asia-Pacific Journal of Ophthalmology: July/August 2021 – Volume 10 – Issue 4 – p 373-380 among others.
6. Roy PS, Singh U, Tadepalli S, Ahuja CK, Bansal D. Retinoblastoma with spinal cord metastasis: When an eye tumor bites the cord!. Indian J Ophthalmol Case Rep 2021;1:842-3
7. Roy PS, Muhammed S, Singh U, Gowravajhala S, Jain R, Trehan A, Bansal D. A single-blinded, randomized controlled trial of standard versus higher dose carboplatin-based intravenous chemotherapy for group D and E retinoblastoma. Pediatr Blood Cancer. 2023 Aug;70(8):e30444. 7. Contributor in: Fabian, I. D., Stacey, A. W., Bowman, R., Khetan, V., Blum, S., Keren-Froim, N., Staffieri, S., Foster, A., & Global Retinoblastoma Study Group (2021). Retinoblastoma management during the COVID-19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries. Pediatric blood & cancer, 68(1), e28584. https://doi.org/10.1002/pbc.28584 8. Vasanthapuram VH, Gupta R, Adulkar N, Nair AG, Tadepalli S, et al. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India. Orbit. 2023 Feb;42(1):30-41.
9. Das, Liza & Singh, Usha & Malhotra, Bhanu & Bhadada, Sanjay & Rastogi, Pulkit & Singh, Paramjeet & Dutaa, Pinaki & Tadepalli, Sameeksha. (2022). Thyroid eye disease with concurrent orbital lymphoma: a radiological surprise. Endocrinology, Diabetes & Metabolism Case Reports. 2022. 10.1530/EDM-21-0109.
10. Ruben M, Eiger-Moscovich M, Yaghy A & Tadepalli S & Shields C (2021). Iodine-125 Plaque Radiotherapy for Retinoblastoma Recurrence Following Intra-arterial Chemotherapy. Journal of Pediatric Ophthalmology & Strabismus. 59. 1-8. 10.3928/01913913-20210903-01.
11. Dalvin L, Bas Z, Tadepalli S, Rao R, Vaidya S, Pacheco R, Shields C (2020). Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. Journal of Pediatric Ophthalmology & Strabismus. 57. 224-234. 10.3928/01913913-20200417-01.

Reviews

Total Reviews – 31

jewel manik

Pediatrician eye ophthalmologist doctor jyoti Matalia checked and for oculoplasty issue consultations done by dr.Sameeksha haripriya..We are pleased to treated from nethralaya with proper instructions..

md kamal

Dr.Sameeksha Haripriya and doctor Pratibha panmand..both checked for eye issue..solution also given..Satisfied

RANGA SWAMY

Cataract surgery went well by dr. sushma Tejwani.. Then today got surgery by dr. sameeksha Maam.. Both time experience was good.. Recommended..

Jonata Battary

First met with senior pediatric eye specialist doctor Jyoti Matalia For my child..Expert And experienced..then for oculoplasty related issue met with dr.Sameeksha haripriya.from first explained everything…really great experience..all have done excellent work..Recommended.

khadeja khatun

Dr.Sameeksha haripriya..oculoplasty problem my child was having.. carefully treated with instructions..

Abubakkar Siddik

Dr.sameeksha haripriya checked properly given and also consult with dr Shrine and dr Pratibha ma’am or relative. pleased to be treated from here

Dilip Muzundar

My wife underwent surgery by dr Sameeksha Haripriya..Carefully treated with exact care..

Salim Reza

Doctor Sameeksha Haripriya refer to doctor shrine Braganza..retina treatments provided..Pleased with all the process and instructions

Moli changdar

Doctor Sameeksha Haripriya and dr.Pratibha panmand..Highly recommendations with great experience

Ashutosh Saha

We came from Bangladesh for eye check up..Doctor jyoti and doctor Sameeksha maam checked for both..guided very well..For me cataract specialist doctor Lubna maam treated..Instructed properly by doctors and staffs also..

Book an Appointment
Call Us